Toru Sakura

Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients

Rika Kihara, Yasunobu Nagata, Hitoshi Kiyoi et al. · Leukemia · 2014 · 233 citations · Full text

Life Sciences, Genetics, Oncology +17

A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study

Shuichi Miyawaki, Shigeki Ohtake, Shin Fujisawa et al. · Blood · 2010 · 175 citations · Full text

Medicine, Oncology, Pharmacology +15

Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11

Yuichi Ishikawa, Naomi Kawashima, Yoshiko Atsuta et al. · Blood Advances · 2020 · 127 citations · Full text

Medicine, Hematology, Oncology +15

Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group

Fumihiko Hayakawa, Toru Sakura, Toshiaki Yujiri et al. · Blood Cancer Journal · 2014 · 105 citations · Full text

Medicine, Oncology, Pediatrics +14

High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSG

Toru Sakura, Fumihiko Hayakawa, Isamu Sugiura et al. · Leukemia · 2017 · 79 citations

Medicine, Oncology, Pharmacology +7